Results
PMID | 25446542 |
Gene Name | MUC16 |
Condition | Endometriosis (Endometriomas (OMAs), deep infiltrating lesions (DIE), and superficial endometriosis (SUP)) |
Association |
Associated |
Population size | 685 |
Population details | 685 (406 women with histologically proven endometriosis, 279 women without endometriosis.) |
Sex | Female |
Other associated phenotypes |
Deep endometriosis |
J Minim Invasive Gynecol. 2015 Feb;22(2):275-84. doi: 10.1016/j.jmig.2014.10.013. Santulli, Pietro| Streuli, Isabelle| Melonio, Isabelle| Marcellin, Louis| M'Baye, Magate| Bititi, Amine| Borghese, Bruno| Lafay Pillet, Marie-Christine| Chapron, Charles Department of Gynecology Obstetrics II and Reproductive Medicine, Universite Paris Descartes, Sorbonne Paris Cite, Faculte de Medecine, AP- HP, Hopital Cochin, Paris, France; Laboratoire d'immunologie, Universite Paris Descartes, Sorbonne Paris Cite, F STUDY OBJECTIVE: To determine whether cancer antigen-125 (CA-125) levels are increased in women with endometriosis, especially in those with endometriomas (OMAs), deep infiltrating lesions (DIE), and superficial endometriosis (SUP) compared with controls without endometriosis in a large cohort of operated women. DESIGN: Cross-sectional study (Canadian Task Force classification II-2). SETTING: Tertiary-care university hospital. PATIENTS: Four hundred six women with histologically proven endometriosis and 279 women without endometriosis. INTERVENTIONS: Surgical examination of the abdomino-pelvic cavity. MEASUREMENTS AND MAIN RESULTS: Preoperative serum CA-125 antigen levels were evaluated by electrochemoluminescence immunoassay in women with endometriosis and controls. Correlations between serum CA-125 levels and clinical and anatomical characteristics of disease severity were examined. Women with endometriosis displayed higher mean serum CA-125 levels compared with disease-free controls (50.1 +/- 62.4 U/mL vs 22.5 +/- 25.2 U/mL; p = .001). CA-125 levels were significantly increased in women with OMA (60.8 +/- 63.5 U/mL) and DIE (55.2 +/- 68.7 U/mL) compared with women with SUP (23.2 +/- 24.5 U/mL) and controls (22.5 +/- 25.2 U/mL). There was no difference in CA-125 levels between patients with SUP and controls and between patients with OMA and DIE. CA-125 serum levels were correlated with DIE severity: the mean number of DIE lesions and worst DIE lesion. CONCLUSION: Serum CA-125 levels were significantly increased in women with severe forms of endometriosis, OMA, and DIE lesions. In addition, elevated serum Ca-125 levels were associated with more severe and extended DIE lesions. In women with superficial peritoneal lesions, CA-125 levels were not different from women without endometriosis. Mesh Terms: Adult| Biomarkers/blood| CA-125 Antigen/*blood| Cross-Sectional Studies| Endometriosis/*blood/*pathology/surgery| Female| France| Humans| Middle Aged| Peritoneum/*pathology| Severity of Illness Index| Young Adult|DA 2015/09/19 06:00 |